Stay up to date...

QUESTIONS ON NOTICE

Questions are currently being updated, please check back soon for previous questions.

135. In a prior round of estimates Prof Skerritt said “No evidence of damage. You seem to be indicating that these are little arrows that are piercing holes in things. The protein by itself does not cause damage”. The vaccine induces an immune response that requires the body’s own cells to be attacked and destroyed. How can Professor Skerritt say the spike protein doesn’t cause any damage or induce a cell-mediated immune attack against host cells that translate the mRNA to spike protein and then place the antigen on the cell surface to invoke an immune response? 136. Does the vaccine contain instructions to turn off the toll like receptors to the mRNA. If so how dangerous is this? 144. The fact that the vaccine spike protein stays in the body for 60 days indicates that it is more toxic than the normal virus which for most people is cleared from the body in a matter of weeks rather than months. Does the TGA disagree with this statement? If so, why?

260. The UK has pulled the vaccine for pregnant women – Why isn’t Australia doing the same thing? 264. FluVax was introduced in 2010. A few babies died from it, some were severely and permanently injured, and 1 in 10 children suffered an adverse event, The vaccine company (CSL) denied responsibility for as long as they could, before the evidence was overwhelming. Why are Health departments continuing with the Covid vaccine rollout that have higher injury rates? There are numerous other examples of where drugs have been pulled on far fewer safety signals.

137. In the post marketing data only 32 of 270 pregnancies were reported on and most of the 32 were miscarriages. Why didn’t the TGA follow up on the other 238 pregnancies and given the missing data how could the TGA say that the vaccine was safe for pregnant women? Was there ever any follow up on the other woman who didn’t initially provide data? 138. I note that the TGA has previously said “Post-market global surveillance data from large numbers of pregnant women have not identified any significant safety concerns with mRNA COVID-19 vaccines given at any stage during pregnancy. There is no evidence of decreased fertility, increased risk of miscarriage or teratogenic risk” Why would the TGA say this given the missing data in the post marketing data and the fact that the vaccine was only tested on pregnant rats?

171. What role does Adjutor play in regulating and approving vaccines – has the TGA outsourced regulatory activities to a third party? 177. Why has the TGA allowed Pfizer/Moderna to set integrity and purity requirements? 265. Why is the Health Department claiming the approval process for the vaccines wasn’t rushed when in fact it was. Furthermore no carcinogenic, genotoxicity or longitudinal studies were completed. And I quote: “The Therapeutic Goods Administration (TGA) provisionally approved these vaccines after a complete assessment of all the available data. This is the same process as any vaccine approved in this country. The TGA will only register and approve a COVID19 vaccine if it is safe and effective.” www.health.gov.au/initiatives-and-programs/covid-19-vaccines/is-it-true/is-it-truewere-covid-19-vaccines-rushed-through-approvals-or-given-emergency-useauthorisations-in-australia.

270. Page 64 – FOI 2389-3-2 – Investigators are not obligated to actively seek AEs or SAEs after the participant has concluded study participation? If investigators don’t have to seek out all adverse events how does the TGA know the investigator has detected all possible side effects? 271. As per Page 64- FOI 2389-3-2 – All pregnancies have to be reported to the sponsor – if this is the case why is so much data on pregnancy missing from the Pfizer Covid vaccine post marketing data? 272. I note on page 69 of FOI 2389-3-2 that adverse events of special interest aren’t applicable but that in the post marketing data there are over 1000 of them mentioned? 273. Of the circa 44,000 participants in the Pfizer Covid vaccine trial how many were checked up at the 6-month, 12 month and 24 month time frame as per the requirements of the CT02-GSOP Clinical Protocol Template Phase 1 2 3 4 (05 December 2019) (around pages 80-90 of 2389-3-2)?

140. On page 47 of the TGA non-clinical report it states no unique in-vivo metabolites of ALC- 0159 were observed in the rat pharmacokinetic study, but N,N-ditetradecylamine formed by slow amide hydrolysis was identified in hepatocytes and liver S9 fractions from mouse, rat, monkey and human – Substances predicted as likely to meet criteria for category 1A or 1B carcinogenicity, mutagenicity, or reproductive toxicity, or with dispersive or diffuse use(s) where predicted likely to meet any classification criterion for health or environmental hazards, or where there is a nanoform soluble in biological and environmental media. https://echa.europa.eu/substance-information/- /substanceinfo/100.037.611 141. Why didn’t the TGA identify the accumulation of N,N-ditetradecylamine a risk from the vaccine?

169. In FOI 2389-3 4.3.3 it says “RNA itself, and the lipids used in the BNT162 vaccines have no carcinogenic or tumorigenic potential. Furthermore, according to ICH SIA, no carcinogenicity studies are required for therapeutics that are not continuously administered. Therefore, no carcinogenicity studies were performed.’ Why is carcinogenicity not tested if boosters are being continually rolled out? 170. In FOI 2389-3 5.3.1.7 regarding coagulation it says “Increases in fibrinogen levels were detected in all vaccinated animals at the end of dosing phase and were consistent with an acute phase response secondary to immune activation and inflammation at the injection sites.” Given clotting was a recognised side effect of the vaccine on what basis can the TGA rule out strokes and other clotting related events? 249. What is the different 5 cap structure in modified RNA – page 109 FOI 2389-3 – how is this different to the Covid spike protein mRNA cap? 250. FOI 2389-3 page 20 – some LNPs can be twice as big as others 60-120 nano metres Does this mean that some vaccine lipids can be twice as toxic or efficacious, or some people will get twice the dose of others? 251. In the Pfizer Covid vaccine as per FOI 2389-3 page 110 Table 2 – Theorical length is from 1200 to 4500 nucleotides depending on selected antigen – the Coronavirus spike protein has 1273 amino acids – why is the vaccine producing a spike protein almost 4 times larger than the Covid virus?

253. In the Pfizer Covid vaccine trial as per Page 33 on FOI 2389-1 – There were 311 candidates in the vaccine group who had other important protocol deviations on or prior to 7 days after Dose 2 – what were these deviations and did they include vaccine injuries? 254. In the Pfizer Covid vaccine trial why were 1790 excluded from valuable efficacy in the placebo group – as per page 33 FOI 2389-1 255. In the Pfizer Covid vaccine trial as per Page 33 on FOI 2389-1 – Why were only around 19,000 from each group evaluated when over 21,000 were vaccinated? 256. In the Pfizer Covid vaccine trial as per Page 33 on FOI 2389-1 – Why were approximately 1250 people pulled from getting the second vaccine?

49. The use of pseudouridine in mRNA vaccines was developed as a very recent concept and its long-term effects are unknown. It has however been known for 10 years that the use of pseudo-U causes the stop codons (required to stop adding amino acids to a protein chain) to misfunction, thereby elongating the protein chain and risking translation of the next segment (the 3’UTR) (Karijolich 2011). The effects of this are unknown and cannot be known without specific experiments to address the issue. When did the TGA become aware that the synthetic nucleotide pseudouridine was being used rather than the natural uridine and what testing did it undertake to ensure that it was safe to use? 50. Studies have shown the psuedouridine has a higher translation error rate than uridine. Wasn’t it reckless to roll out the vaccine knowing that? Improving the fidelity of uridine analog incorporation during in vitro transcription | bioRxiv (available at: www.biorxiv.org/content/10.1101/2022.04.12.488100v1)

52. FOI 3471 shows contamination in the batches. Why didn’t the TGA undertake whole genome sequencing on the batches when it was an obvious way to look for contamination? 53. As per the TGA FOI disclosure log that some batches had up to 40% degraded mRNA – what are the potential risks of degraded mRNA in the body and what studies were carried to determine the safety of degraded mRNA? 54. How does the TGA know degraded mRNA isn’t going to produce toxic proteins? 55. How did the TGA undertake batch testing. Are all vials tested and what were the benchmarks especially in regards to tolerance levels? 56. Did the Covid-19 vaccine trail undertaken by Pfizer use batches made via the commercial process or the laboratory process? Are there trials undertaken by Pfizer using the commercial process and if so can they be provided? 57. Can the TGA report batch numbers by number of reported adverse events and reported deaths so people can see which batches had the highest rate of adverse events? 58. Could the TGA please provide evidence that the Covid vaccine batches had the same purity in Australia as what was stated in the manufacturing facility. Could documentation of the signatures and percentage of intact mRNA by both the manufacturer and the TGA please be provided? 59. Why did the TGA approve batches with as low as 60% integrity and how can it guarantee safety of those batches from degraded mRNA and further degradation after transport? 60. Why is the integrity level of batches commercial in confidence? This is a safety issue that Australians should be aware of it is it not? 61. If a batch is only 60% intact and each vial contains 5 doses how can the TGA be sure that every person is getting a consistent dose? 62. FOI 2389-3 page 110 Table 2 says concentration depends on batch size? How can the TGA be sure that every person is getting a consistent dose?

63. Is it possible that the extreme length of the poly-A tail is contributing to longevity. The Roltgen cell paper (https://www.sciencedirect.com/science/article/pii/S0092867422000769) shows mRNA at 60 days post injection still producing spike antigen. Won’t this lead to t-cell exhaustion, as well as risking p53-dependent carcinogenesis risk? Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination (cell.com) 64. Doesn’t the pathway used by the mRNA vaccine to instruct the body cell’s to produce a toxic spike protein increase the risk of harm to the body? Isn’t the name of the game to kill the pathogen rather than reproduce it on an unknown time basis? 65. Does the vaccine induce an autoimmune response – either by T-cells attaching your own cells or white blood cells attacking protein (whatever its form) created by the vaccine and exported from the cell?

66. Studies carried out on the lipid in rat trials showed it entered most body organs. Given that lipid concentrations were still increasing in most body organs, most notably the ovaries where it doubled from day 1 to day 2, why did the TGA not request more testing from Pfizer to determine just how long the lipids stay in the body before approving their vaccine? 67. How can the TGA guarantee that lipids that have entered body organs won’t damage those organs without longitudinal testing? 68. Why were biodistribution studies stopped after 9 days when it has been shown that mRNA, Lipids and spike proteins had been found in the body up to 60 days after the second vaccination? How can the TGA say with any confidence what the lifespan of the spike protein if they never tested it? Why didn’t the sponsor continue the trials given concentrations were increasing? 69. Why were no biodistribution studies performed with the spike protein? 70. Has the TGA now got comprehensive and exhaustive data that determines how long the lipids stay in the body. If not, then why are they allowing the rollout of the vaccine to continue? 75. Why is the lipid travelling around the body in increasing concentrations when many Health professionals said it would stay at the injection site?

155. There are almost 20,000 serious injuries to date out of 20 million recipients in a 12- month period since the rollout began. This is an injury rate of 1 in 1000 people who have received the vaccine. This higher than the 1 in 3000 Prof Skerrit mentioned in regard to multi-inflammatory disease and also the few in a million side effects he quoted with John Laws. Given the rate of serious injury from the Covid-19 vaccine shouldn’t they be withdrawn? 156. What is the source of Prof Skerritt’s claim that Covid-19 causes multi-inflammatory disease in 1 in 3000 children? Can the source please be provided? 192. According to Moderna serious adverse events were recorded at one in 200 for six months to five years yet the TGA still approved this jab. Why did they do that knowing that the risk of the jab was 15 times greater than multi-inflammatory disease? I note factcheckers are claiming some of the trial participants already had underlying issues and that only one was an adverse event. This is still one in 1760 which is higher than one in 3000. https://www.nejm.org/doi/full/10.1056/NEJMoa2209367

161. “Pfizer has asked a U.S. court to throw out a lawsuit from a whistle-blower who revealed problems at sites that tested Pfizer’s COVID-19 vaccine. Pfizer stated that the regulations don’t apply to its vaccine contract with the U.S. Department of Defence because the agreement gives contract holders the ability to skirt many rules and laws that typically apply to contracts.” Pfizer Moves to Dismiss Lawsuit From COVID-19 Vaccine Trial, Citing ‘Prototype’ Agreement (theepochtimes.com) – Has Australia signed a Covid-19 contract with Pfizer that has similar conditions? 162. Why are you penalising Australians $10,000 of dollars for importing Ivermectin worth $40 but doing nothing about Pfizer not living up to its promise about the safety and efficacy of the vaccine? 165. Can the TGA provide all correspondence with Pfizer regarding the Covid vaccine in regards to purchase agreements, testing and safety concerns? 183. Is the vaccine injury scheme going to be updated to include additional side effects that have been reported to the TGA by Health Professionals rather than Pfizer who have a conflict of interest in reporting side effects from their own drugs? 191. The normal default for contracts is to reserve a “right” to buy. Are these the terms the Pfizer Covid vaccine contract was based on, or do have an “obligation” to buy the Covid vaccines regardless of performance? If so, why did the health department deviate from the normal procedure for a contract that covers Australia’s needs many times over, for a period where all would already be vaccinated (2022 and 2023). 262. The contract between Pfizer and the US government prohibits independent researchers from studying the vaccines. They claim it would ‘divert’ these precious resources away from their intended use fulfilling an ‘urgent’ need. Is this true? If so, then why is Pfizer hiding from independent scrutiny?

71. Has the TGA now got comprehensive and exhaustive data that determines how long the body produces the Spike protein. If not, then why are they allowing the rollout of the vaccine to continue? 72. Has the TGA now got comprehensive and exhaustive data that determines how long the spike protein or any other related prions, mutations stay in the body and by body organ type. If not, then why are they allowing the rollout of the vaccine to continue? 73. Do expressed spike proteins stay in the cell membrane or are they secreted via exosomes? 74. The ribosomes on the endoplasmic reticulum produce protein for export while ribosome in the cytoplasm produce proteins for use inside the cell. Given the TGA non-clinical report says the spike protein is produced via the endoplasmic reticulum then isn’t evidence that spike proteins will be exported from the cell and potentially re-enter the circulatory system? 76. Which part of the mRNA code tells the mRNA to attach to the Endoplasmic Reticulum? 77. What evidence does the TGA have that the spike protein doesn’t go into the nucleus – the delivery of the spike protein was never tested. There were no studies carried out so how would the TGA know with 100% certainty the mRNA or the spike protein doesn’t enter the nucleus? 78. Is there any evidence that the spike protein does not inhibit the P53 gene? Were studies carried out to prove this? 79. “Another study revealed that extracellular vesicles decorated with S-proteins persist up to 4 months after vaccination… This raises the possibility that LNP–mRNA remain in circulation for extended periods of time, retaining their ability to induce S-protein expression….”. Does the TGA refute this study? www.mdpi.com/2227- 9059/10/7/1538/htm 87. Have studies been conducted by the TGA to determine if the spike protein interferes with oocytes?

19. I have previously asked why does the TGA override doctors who have lodged adverse event claims of death and the TGA replied – “The premise of the statement by the Senator is wrong. Reporting of an adverse event to the Therapeutic Goods Administration (TGA) does not mean that the reporting doctor considers that it was caused by a vaccine.” This reply is unsatisfactory. If they have ticked the box “suspected” it means they do consider the vaccine contributed to the death – SQ22-000105. To quote one doctor “Doctors and nurses only report suspected drug reactions to the DAEN. We do not have the time to waste reporting a broken leg as an adverse drug reaction. The DAEN report takes about 20-30 minutes and we are very aware, having to put our name to the reports, that the report could be used against us if we were to be found making vexatious, superficial or spurious reports. 20. All drug reactions reported by doctors and nurses are therefore suspected to be linked to the drug, by definition. That is what the DAEN is for. It says it on the front page of the reporting section (see screenshot).’ Why is the TGA downplaying reported deaths from vaccines and in doing so is acting negligently? 37. Studies are now showing negative efficacy with vaccination in regards to hospitalisation and death from 6-20 weeks after the vaccine. What does the TGA have to say about the long term safety and cost benefit analysis of the vaccine? 38. How long does it take to investigate an adverse event report? 39. I note the TGA have around 60 staff looking at adverse events – was this enough given the large number of reported injuries. This would have given staff approximately 30 minutes on average to investigate every injury – how was this enough time to investigate thoroughly?

22. Of the more than 900 reported Covid vaccine deaths, how many have been subject to causality assessments or autopsies to determine if they were caused by the vaccine? 23. Shouldn’t every suspected death be reported to the coroner for greater analysis rather than rely on a hands-off TGA report for relevance to the vaccine? 24. Can the TGA please provide all paperwork relating to reported deaths from the vaccine. Name can be redacted. Data can be provided via a softcopy. 25. Is the TGA willing to have an audit conducted on the review of deaths by the vaccine – if not, why not? 26. If a reported death occurs within 14 days after receiving a vaccine was this considered a vaccinated or unvaccinated case by the TGA? i.e. are all suspected deaths reported to the TGA regarded as vaccine death regardless of the time between the date of death and date of vaccine? 27. Actual deaths per month jumped dramatically after the rollout of the Covid vaccine in May 2021, yet before Covid was even in the community. This is an extremely strong temporal signal that the vaccine is causing an increase in deaths. Why is the Health Department/TGA discounting the fact that the increase in actual deaths throughout 2021 are not related to the vaccine? 28. When the death rate is broken out by age the increase in deaths is actually over 10% from May 2021 for 75 and older cohorts. -Given the Pfizer vaccine wasn’t tested on people older the 75 (in any significant numbers – See Table 1 2389-1) why is the TGA continuing to roll out the jab given real world evidence is suggesting an extremely strong correlation/causation with deaths in older people? 29. Are deaths being tracked by vaccination status? This would indicate whether or not excess deaths are being driven by the vaccinated or unvaccinated, wouldn’t it 30. Is the time between death and time from vaccination status being recorded – if not why not – this is still a provisional vaccine? If so, can the TGA please provide an excel spreadsheet of deidentified data showing date of vaccination and date of death for deaths in Australia since the rollout of the vaccine began? 31. How many reported deaths died within 2, days, 14 days, 30 days and 60 days of taking the vaccine? 32. Are only fully paid TGA staff assessing vaccine deaths or has this been outsourced to other agencies? If so, do these agencies have conflicts of interest? 33. Please provide the methodology used by the TGA that justifies discrediting (99%) of the reports made by health professionals on behalf of their dead patients that the cause of death resulted from the vaccines? 36. Does the TGA or State or Territory health departments require autopsies to be performed on persons dying at any time post COVID-19 vaccination? If not, why not? 40. Why does the TGA believe that the deaths reported to the DEAN are false and misleading (AFN factcheck 03/09/2022) – these reports are ticked as suspected and over 70% come from health professionals – what right does the TGA have to dismiss them?

2. Mr Fletcher said only 28 doctors were suspended for presumably Covid vaccine related matters. Are these current suspensions, or all the suspensions since the rollout began? 3. What were the reasons for the suspensions? 5. Why are complaints about health professionals able to remain anonymous? How can health professionals defend themselves when they don’t know who is complaining about them? 6. Why can AHPRA suspend health professionals based on hearsay complaints that can also remain anonymous? Why isn’t the weight of evidence higher? 7. What checks and balances do AHPRA have in place to ensure that complaints about health professionals are not vexatious? 8. Does AHPRA receive complaints from pharmaceutical companies about health professionals? If so, what are they about? 9. Can AHPRA provide all correspondence between Pfizer and AHPRA regarding their Covid-19 vaccine regarding any complaints they may have lodged?

135. In a prior round of estimates Prof Skerritt said “No evidence of damage. You seem to be indicating that these are little arrows that are piercing holes in things. The protein by itself does not cause damage”. The vaccine induces an immune response that requires the body’s own cells to be attacked and destroyed. How can Professor Skerritt say the spike protein doesn’t cause any damage or induce a cell-mediated immune attack against host cells that translate the mRNA to spike protein and then place the antigen on the cell surface to invoke an immune response? 136. Does the vaccine contain instructions to turn off the toll like receptors to the mRNA. If so how dangerous is this? 144. The fact that the vaccine spike protein stays in the body for 60 days indicates that it is more toxic than the normal virus which for most people is cleared from the body in a matter of weeks rather than months. Does the TGA disagree with this statement? If so, why?

260. The UK has pulled the vaccine for pregnant women – Why isn’t Australia doing the same thing? 264. FluVax was introduced in 2010. A few babies died from it, some were severely and permanently injured, and 1 in 10 children suffered an adverse event, The vaccine company (CSL) denied responsibility for as long as they could, before the evidence was overwhelming. Why are Health departments continuing with the Covid vaccine rollout that have higher injury rates? There are numerous other examples of where drugs have been pulled on far fewer safety signals.

137. In the post marketing data only 32 of 270 pregnancies were reported on and most of the 32 were miscarriages. Why didn’t the TGA follow up on the other 238 pregnancies and given the missing data how could the TGA say that the vaccine was safe for pregnant women? Was there ever any follow up on the other woman who didn’t initially provide data? 138. I note that the TGA has previously said “Post-market global surveillance data from large numbers of pregnant women have not identified any significant safety concerns with mRNA COVID-19 vaccines given at any stage during pregnancy. There is no evidence of decreased fertility, increased risk of miscarriage or teratogenic risk” Why would the TGA say this given the missing data in the post marketing data and the fact that the vaccine was only tested on pregnant rats?

171. What role does Adjutor play in regulating and approving vaccines – has the TGA outsourced regulatory activities to a third party? 177. Why has the TGA allowed Pfizer/Moderna to set integrity and purity requirements? 265. Why is the Health Department claiming the approval process for the vaccines wasn’t rushed when in fact it was. Furthermore no carcinogenic, genotoxicity or longitudinal studies were completed. And I quote: “The Therapeutic Goods Administration (TGA) provisionally approved these vaccines after a complete assessment of all the available data. This is the same process as any vaccine approved in this country. The TGA will only register and approve a COVID19 vaccine if it is safe and effective.” www.health.gov.au/initiatives-and-programs/covid-19-vaccines/is-it-true/is-it-truewere-covid-19-vaccines-rushed-through-approvals-or-given-emergency-useauthorisations-in-australia.

270. Page 64 – FOI 2389-3-2 – Investigators are not obligated to actively seek AEs or SAEs after the participant has concluded study participation? If investigators don’t have to seek out all adverse events how does the TGA know the investigator has detected all possible side effects? 271. As per Page 64- FOI 2389-3-2 – All pregnancies have to be reported to the sponsor – if this is the case why is so much data on pregnancy missing from the Pfizer Covid vaccine post marketing data? 272. I note on page 69 of FOI 2389-3-2 that adverse events of special interest aren’t applicable but that in the post marketing data there are over 1000 of them mentioned? 273. Of the circa 44,000 participants in the Pfizer Covid vaccine trial how many were checked up at the 6-month, 12 month and 24 month time frame as per the requirements of the CT02-GSOP Clinical Protocol Template Phase 1 2 3 4 (05 December 2019) (around pages 80-90 of 2389-3-2)?

140. On page 47 of the TGA non-clinical report it states no unique in-vivo metabolites of ALC- 0159 were observed in the rat pharmacokinetic study, but N,N-ditetradecylamine formed by slow amide hydrolysis was identified in hepatocytes and liver S9 fractions from mouse, rat, monkey and human – Substances predicted as likely to meet criteria for category 1A or 1B carcinogenicity, mutagenicity, or reproductive toxicity, or with dispersive or diffuse use(s) where predicted likely to meet any classification criterion for health or environmental hazards, or where there is a nanoform soluble in biological and environmental media. https://echa.europa.eu/substance-information/- /substanceinfo/100.037.611 141. Why didn’t the TGA identify the accumulation of N,N-ditetradecylamine a risk from the vaccine?

169. In FOI 2389-3 4.3.3 it says “RNA itself, and the lipids used in the BNT162 vaccines have no carcinogenic or tumorigenic potential. Furthermore, according to ICH SIA, no carcinogenicity studies are required for therapeutics that are not continuously administered. Therefore, no carcinogenicity studies were performed.’ Why is carcinogenicity not tested if boosters are being continually rolled out? 170. In FOI 2389-3 5.3.1.7 regarding coagulation it says “Increases in fibrinogen levels were detected in all vaccinated animals at the end of dosing phase and were consistent with an acute phase response secondary to immune activation and inflammation at the injection sites.” Given clotting was a recognised side effect of the vaccine on what basis can the TGA rule out strokes and other clotting related events? 249. What is the different 5 cap structure in modified RNA – page 109 FOI 2389-3 – how is this different to the Covid spike protein mRNA cap? 250. FOI 2389-3 page 20 – some LNPs can be twice as big as others 60-120 nano metres Does this mean that some vaccine lipids can be twice as toxic or efficacious, or some people will get twice the dose of others? 251. In the Pfizer Covid vaccine as per FOI 2389-3 page 110 Table 2 – Theorical length is from 1200 to 4500 nucleotides depending on selected antigen – the Coronavirus spike protein has 1273 amino acids – why is the vaccine producing a spike protein almost 4 times larger than the Covid virus?

253. In the Pfizer Covid vaccine trial as per Page 33 on FOI 2389-1 – There were 311 candidates in the vaccine group who had other important protocol deviations on or prior to 7 days after Dose 2 – what were these deviations and did they include vaccine injuries? 254. In the Pfizer Covid vaccine trial why were 1790 excluded from valuable efficacy in the placebo group – as per page 33 FOI 2389-1 255. In the Pfizer Covid vaccine trial as per Page 33 on FOI 2389-1 – Why were only around 19,000 from each group evaluated when over 21,000 were vaccinated? 256. In the Pfizer Covid vaccine trial as per Page 33 on FOI 2389-1 – Why were approximately 1250 people pulled from getting the second vaccine?

49. The use of pseudouridine in mRNA vaccines was developed as a very recent concept and its long-term effects are unknown. It has however been known for 10 years that the use of pseudo-U causes the stop codons (required to stop adding amino acids to a protein chain) to misfunction, thereby elongating the protein chain and risking translation of the next segment (the 3’UTR) (Karijolich 2011). The effects of this are unknown and cannot be known without specific experiments to address the issue. When did the TGA become aware that the synthetic nucleotide pseudouridine was being used rather than the natural uridine and what testing did it undertake to ensure that it was safe to use? 50. Studies have shown the psuedouridine has a higher translation error rate than uridine. Wasn’t it reckless to roll out the vaccine knowing that? Improving the fidelity of uridine analog incorporation during in vitro transcription | bioRxiv (available at: www.biorxiv.org/content/10.1101/2022.04.12.488100v1)

52. FOI 3471 shows contamination in the batches. Why didn’t the TGA undertake whole genome sequencing on the batches when it was an obvious way to look for contamination? 53. As per the TGA FOI disclosure log that some batches had up to 40% degraded mRNA – what are the potential risks of degraded mRNA in the body and what studies were carried to determine the safety of degraded mRNA? 54. How does the TGA know degraded mRNA isn’t going to produce toxic proteins? 55. How did the TGA undertake batch testing. Are all vials tested and what were the benchmarks especially in regards to tolerance levels? 56. Did the Covid-19 vaccine trail undertaken by Pfizer use batches made via the commercial process or the laboratory process? Are there trials undertaken by Pfizer using the commercial process and if so can they be provided? 57. Can the TGA report batch numbers by number of reported adverse events and reported deaths so people can see which batches had the highest rate of adverse events? 58. Could the TGA please provide evidence that the Covid vaccine batches had the same purity in Australia as what was stated in the manufacturing facility. Could documentation of the signatures and percentage of intact mRNA by both the manufacturer and the TGA please be provided? 59. Why did the TGA approve batches with as low as 60% integrity and how can it guarantee safety of those batches from degraded mRNA and further degradation after transport? 60. Why is the integrity level of batches commercial in confidence? This is a safety issue that Australians should be aware of it is it not? 61. If a batch is only 60% intact and each vial contains 5 doses how can the TGA be sure that every person is getting a consistent dose? 62. FOI 2389-3 page 110 Table 2 says concentration depends on batch size? How can the TGA be sure that every person is getting a consistent dose?

63. Is it possible that the extreme length of the poly-A tail is contributing to longevity. The Roltgen cell paper (https://www.sciencedirect.com/science/article/pii/S0092867422000769) shows mRNA at 60 days post injection still producing spike antigen. Won’t this lead to t-cell exhaustion, as well as risking p53-dependent carcinogenesis risk? Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination (cell.com) 64. Doesn’t the pathway used by the mRNA vaccine to instruct the body cell’s to produce a toxic spike protein increase the risk of harm to the body? Isn’t the name of the game to kill the pathogen rather than reproduce it on an unknown time basis? 65. Does the vaccine induce an autoimmune response – either by T-cells attaching your own cells or white blood cells attacking protein (whatever its form) created by the vaccine and exported from the cell?

66. Studies carried out on the lipid in rat trials showed it entered most body organs. Given that lipid concentrations were still increasing in most body organs, most notably the ovaries where it doubled from day 1 to day 2, why did the TGA not request more testing from Pfizer to determine just how long the lipids stay in the body before approving their vaccine? 67. How can the TGA guarantee that lipids that have entered body organs won’t damage those organs without longitudinal testing? 68. Why were biodistribution studies stopped after 9 days when it has been shown that mRNA, Lipids and spike proteins had been found in the body up to 60 days after the second vaccination? How can the TGA say with any confidence what the lifespan of the spike protein if they never tested it? Why didn’t the sponsor continue the trials given concentrations were increasing? 69. Why were no biodistribution studies performed with the spike protein? 70. Has the TGA now got comprehensive and exhaustive data that determines how long the lipids stay in the body. If not, then why are they allowing the rollout of the vaccine to continue? 75. Why is the lipid travelling around the body in increasing concentrations when many Health professionals said it would stay at the injection site?

155. There are almost 20,000 serious injuries to date out of 20 million recipients in a 12- month period since the rollout began. This is an injury rate of 1 in 1000 people who have received the vaccine. This higher than the 1 in 3000 Prof Skerrit mentioned in regard to multi-inflammatory disease and also the few in a million side effects he quoted with John Laws. Given the rate of serious injury from the Covid-19 vaccine shouldn’t they be withdrawn? 156. What is the source of Prof Skerritt’s claim that Covid-19 causes multi-inflammatory disease in 1 in 3000 children? Can the source please be provided? 192. According to Moderna serious adverse events were recorded at one in 200 for six months to five years yet the TGA still approved this jab. Why did they do that knowing that the risk of the jab was 15 times greater than multi-inflammatory disease? I note factcheckers are claiming some of the trial participants already had underlying issues and that only one was an adverse event. This is still one in 1760 which is higher than one in 3000. https://www.nejm.org/doi/full/10.1056/NEJMoa2209367

161. “Pfizer has asked a U.S. court to throw out a lawsuit from a whistle-blower who revealed problems at sites that tested Pfizer’s COVID-19 vaccine. Pfizer stated that the regulations don’t apply to its vaccine contract with the U.S. Department of Defence because the agreement gives contract holders the ability to skirt many rules and laws that typically apply to contracts.” Pfizer Moves to Dismiss Lawsuit From COVID-19 Vaccine Trial, Citing ‘Prototype’ Agreement (theepochtimes.com) – Has Australia signed a Covid-19 contract with Pfizer that has similar conditions? 162. Why are you penalising Australians $10,000 of dollars for importing Ivermectin worth $40 but doing nothing about Pfizer not living up to its promise about the safety and efficacy of the vaccine? 165. Can the TGA provide all correspondence with Pfizer regarding the Covid vaccine in regards to purchase agreements, testing and safety concerns? 183. Is the vaccine injury scheme going to be updated to include additional side effects that have been reported to the TGA by Health Professionals rather than Pfizer who have a conflict of interest in reporting side effects from their own drugs? 191. The normal default for contracts is to reserve a “right” to buy. Are these the terms the Pfizer Covid vaccine contract was based on, or do have an “obligation” to buy the Covid vaccines regardless of performance? If so, why did the health department deviate from the normal procedure for a contract that covers Australia’s needs many times over, for a period where all would already be vaccinated (2022 and 2023). 262. The contract between Pfizer and the US government prohibits independent researchers from studying the vaccines. They claim it would ‘divert’ these precious resources away from their intended use fulfilling an ‘urgent’ need. Is this true? If so, then why is Pfizer hiding from independent scrutiny?

71. Has the TGA now got comprehensive and exhaustive data that determines how long the body produces the Spike protein. If not, then why are they allowing the rollout of the vaccine to continue? 72. Has the TGA now got comprehensive and exhaustive data that determines how long the spike protein or any other related prions, mutations stay in the body and by body organ type. If not, then why are they allowing the rollout of the vaccine to continue? 73. Do expressed spike proteins stay in the cell membrane or are they secreted via exosomes? 74. The ribosomes on the endoplasmic reticulum produce protein for export while ribosome in the cytoplasm produce proteins for use inside the cell. Given the TGA non-clinical report says the spike protein is produced via the endoplasmic reticulum then isn’t evidence that spike proteins will be exported from the cell and potentially re-enter the circulatory system? 76. Which part of the mRNA code tells the mRNA to attach to the Endoplasmic Reticulum? 77. What evidence does the TGA have that the spike protein doesn’t go into the nucleus – the delivery of the spike protein was never tested. There were no studies carried out so how would the TGA know with 100% certainty the mRNA or the spike protein doesn’t enter the nucleus? 78. Is there any evidence that the spike protein does not inhibit the P53 gene? Were studies carried out to prove this? 79. “Another study revealed that extracellular vesicles decorated with S-proteins persist up to 4 months after vaccination… This raises the possibility that LNP–mRNA remain in circulation for extended periods of time, retaining their ability to induce S-protein expression….”. Does the TGA refute this study? www.mdpi.com/2227- 9059/10/7/1538/htm 87. Have studies been conducted by the TGA to determine if the spike protein interferes with oocytes?

19. I have previously asked why does the TGA override doctors who have lodged adverse event claims of death and the TGA replied – “The premise of the statement by the Senator is wrong. Reporting of an adverse event to the Therapeutic Goods Administration (TGA) does not mean that the reporting doctor considers that it was caused by a vaccine.” This reply is unsatisfactory. If they have ticked the box “suspected” it means they do consider the vaccine contributed to the death – SQ22-000105. To quote one doctor “Doctors and nurses only report suspected drug reactions to the DAEN. We do not have the time to waste reporting a broken leg as an adverse drug reaction. The DAEN report takes about 20-30 minutes and we are very aware, having to put our name to the reports, that the report could be used against us if we were to be found making vexatious, superficial or spurious reports. 20. All drug reactions reported by doctors and nurses are therefore suspected to be linked to the drug, by definition. That is what the DAEN is for. It says it on the front page of the reporting section (see screenshot).’ Why is the TGA downplaying reported deaths from vaccines and in doing so is acting negligently? 37. Studies are now showing negative efficacy with vaccination in regards to hospitalisation and death from 6-20 weeks after the vaccine. What does the TGA have to say about the long term safety and cost benefit analysis of the vaccine? 38. How long does it take to investigate an adverse event report? 39. I note the TGA have around 60 staff looking at adverse events – was this enough given the large number of reported injuries. This would have given staff approximately 30 minutes on average to investigate every injury – how was this enough time to investigate thoroughly?

22. Of the more than 900 reported Covid vaccine deaths, how many have been subject to causality assessments or autopsies to determine if they were caused by the vaccine? 23. Shouldn’t every suspected death be reported to the coroner for greater analysis rather than rely on a hands-off TGA report for relevance to the vaccine? 24. Can the TGA please provide all paperwork relating to reported deaths from the vaccine. Name can be redacted. Data can be provided via a softcopy. 25. Is the TGA willing to have an audit conducted on the review of deaths by the vaccine – if not, why not? 26. If a reported death occurs within 14 days after receiving a vaccine was this considered a vaccinated or unvaccinated case by the TGA? i.e. are all suspected deaths reported to the TGA regarded as vaccine death regardless of the time between the date of death and date of vaccine? 27. Actual deaths per month jumped dramatically after the rollout of the Covid vaccine in May 2021, yet before Covid was even in the community. This is an extremely strong temporal signal that the vaccine is causing an increase in deaths. Why is the Health Department/TGA discounting the fact that the increase in actual deaths throughout 2021 are not related to the vaccine? 28. When the death rate is broken out by age the increase in deaths is actually over 10% from May 2021 for 75 and older cohorts. -Given the Pfizer vaccine wasn’t tested on people older the 75 (in any significant numbers – See Table 1 2389-1) why is the TGA continuing to roll out the jab given real world evidence is suggesting an extremely strong correlation/causation with deaths in older people? 29. Are deaths being tracked by vaccination status? This would indicate whether or not excess deaths are being driven by the vaccinated or unvaccinated, wouldn’t it 30. Is the time between death and time from vaccination status being recorded – if not why not – this is still a provisional vaccine? If so, can the TGA please provide an excel spreadsheet of deidentified data showing date of vaccination and date of death for deaths in Australia since the rollout of the vaccine began? 31. How many reported deaths died within 2, days, 14 days, 30 days and 60 days of taking the vaccine? 32. Are only fully paid TGA staff assessing vaccine deaths or has this been outsourced to other agencies? If so, do these agencies have conflicts of interest? 33. Please provide the methodology used by the TGA that justifies discrediting (99%) of the reports made by health professionals on behalf of their dead patients that the cause of death resulted from the vaccines? 36. Does the TGA or State or Territory health departments require autopsies to be performed on persons dying at any time post COVID-19 vaccination? If not, why not? 40. Why does the TGA believe that the deaths reported to the DEAN are false and misleading (AFN factcheck 03/09/2022) – these reports are ticked as suspected and over 70% come from health professionals – what right does the TGA have to dismiss them?

2. Mr Fletcher said only 28 doctors were suspended for presumably Covid vaccine related matters. Are these current suspensions, or all the suspensions since the rollout began? 3. What were the reasons for the suspensions? 5. Why are complaints about health professionals able to remain anonymous? How can health professionals defend themselves when they don’t know who is complaining about them? 6. Why can AHPRA suspend health professionals based on hearsay complaints that can also remain anonymous? Why isn’t the weight of evidence higher? 7. What checks and balances do AHPRA have in place to ensure that complaints about health professionals are not vexatious? 8. Does AHPRA receive complaints from pharmaceutical companies about health professionals? If so, what are they about? 9. Can AHPRA provide all correspondence between Pfizer and AHPRA regarding their Covid-19 vaccine regarding any complaints they may have lodged?

THE ISSUES

Click on an interest area to read articles and learn more about the work I am doing in Parliament.

Taxation, Finance & Economy

READ MORE

Education & Family

READ MORE

Energy

READ MORE

Environment

READ MORE

Health, Aged Care & Seniors

READ MORE

Primary Industries

READ MORE

Immigration & Foreign Affairs

READ MORE

Infrastructure, Manufacturing, Transport & Tourism

READ MORE

Defence

READ MORE

Federation Reform

READ MORE

I may get kicked off social media soon for speaking too much truth so please join my mailing list so we can always stay in touch...

Thank you,

Gerard